Series C - 4D Molecular Therapeutics - Jun 16, 2020 Funding Round Profile - Cointime

Bitcoin $79,638.87 +4.29%
Ethereum $3,201.45 +5.46%
BNB $636.06 +1.87%
Optimism $1.70 +5.23%
Arbitrum $0.64 +6.35%
Solana $205.91 +2.75%
Polygon $0.41 +7.00%
Cosmos $5.43 +15.18%
Avalanche $32.43 +11.27%

Bitcoin $79,638.87 +4.29%
Ethereum $3,201.45 +5.46%
BNB $636.06 +1.87%
Optimism $1.70 +5.23%
Arbitrum $0.64 +6.35%
Solana $205.91 +2.75%
Polygon $0.41 +7.00%
Cosmos $5.43 +15.18%
Avalanche $32.43 +11.27%

4D Molecular Therapeutics

company

Funding Round

Series C

Money Raised

$ 75M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
MiraeAsset Financial Group	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 5, 2018	Series B	$ 90M	CureDuchenne Ventures	Detail